Clin psychopharmacol neurosci impact factor
WebAbout Journal of Psychopharmacology. The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal ... WebJournal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug …
Clin psychopharmacol neurosci impact factor
Did you know?
WebMay 27, 2024 · The impact score (IS) 2024 of International Clinical Psychopharmacology is 1.89, which is computed in 2024 as per its definition.International Clinical … WebNov 9, 2024 · Yuluğ B, Ozan E, Kilic E. Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. J Neuropsychiatry Clin Neurosci . 2010;22(1).
WebFeb 29, 2024 · Clin Psychopharmacol Neurosci. 2024 Feb 29;18(1):75-80. doi: 10.9758/cpn.2024.18.1.75. Authors Jeewon Lee 1 , Areum Lee 1 , Ji-Hoon Kim 2 , Yun Mi Shin 3 , Seong-Ju Kim 3 , Woo Dong Cho 3 , Soyoung Irene Lee 1 Affiliations 1 Department of Psychiatry, Soonchunhyang University Bucheon ... WebImpact Factor: 4.562 / 5-Year Impact Factor: 5.415 . JOURNAL HOMEPAGE. SUBMIT PAPER. Close ... J Clin Psychopharmacol 13: 383-390. Google Scholar. Kilian J G, Kerr K, Lawrence C, Celermajer D S (1999) Myocarditis and cardiomyopathy associated with clozapine . ... J Neuropsychiatry Clin Neurosci 11: 117-118. Google Scholar. Pantelis C, …
WebMay 1, 2024 · Clin Psychopharmacol Neurosci 2015; 13:150–156Crossref, Medline, Google Scholar. 13 Pérez V, Espadaler J, Tuson M, et al: Effectiveness of pharmacogenetic information in the treatment of major depressive disorder: results from the AB-GEN randomized clinical trial. Programme of the 29th European College of …
WebMay 27, 2024 · The impact score (IS) 2024 of International Clinical Psychopharmacology is 1.89, which is computed in 2024 as per its definition.International Clinical Psychopharmacology IS is increased by a factor of 0.36 and approximate percentage change is 23.53% when compared to preceding year 2024, which shows a …
WebInternational Scientific Journal & Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals thwing-albert fp2260WebData were also analyzed from a short-term (12-week), randomized, active-controlled trial of flexible-dose treatment with vortioxetine (10–20 mg/day) compared with agomelatine (25–50 mg/day) in patients with MDD who had an inadequate response to SSRI/SNRI monotherapy (NCT01488071). 47 This study was included as agomelatine was shown to be effective … thw infrastrukturWebNov 1, 2024 · The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study. Oh SY 1, Jon ... Clin Psychopharmacol Neurosci. 2024; 16:361–375. doi: 10.9758/cpn.2024.16.4.361. [Europe PMC free article] [Google Scholar] 8. Ardic UA, Küçükköse M, Inci SB, Ercan ES. ... thwing albert ejaWebScope. Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of … th windows and doorsWebFeb 28, 2024 · Clin Psychopharmacol Neurosci. 2024 Feb 28;19(1):155-159. doi: 10.9758/cpn.2024.19.1.155. Authors ... Objective: Weight gain is an important risk factor for morbidity and mortality among patients with schizophrenia. We speculated that positive symptoms, related to dopaminergic hyperactivity and altered mesolimbic function, are … thwing-albert fp-2260WebAug 1, 2024 · Clin Psychopharmacol Neurosci. 2024 Aug; 16(3): 349–357. Published online 2024 Aug 31. doi: 10.9758/cpn.2024.16.3 ... Fukui N, Sugai T, Watanabe J, Ono S, et al. Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia. J Clin Psychopharmacol. 2013; … thwing-albertWebJ. Clin. Psychopharmacol. The Journal of Clinical Psychopharmacology is a peer-reviewed medical journal published by Lippincott Williams & Wilkins covering clinical psychopharmacology. It was founded by Richard I. Shader, MD in 1981 as the first journal of an international scope devoted solely to clinical psychopharmacology. [1] thwing-albert co